Drug intelligence / Profile preview

Apo-Si-K170A-C76

Development stage
Phase 1
Lead developer
Interna Therapeutics
Modality
Small Molecules
Administration
Intranasal
01

Overview

Apo-Si-K170A-C76 is an investigational pharmaceutical drug currently in phase 1 clinical development, administered via **intranasal spray**. Its primary purpose in clinical studies is to evaluate safety, tolerability, and systemic exposure in healthy adult subjects. The drug is delivered in ascending single and repeated twice-daily (BID) doses using a nasal spray device at a concentration of 20 mg/mL, with dosing varying by cohort. The developer and sponsor of the clinical trial is Interna Therapeutics Ltd. (formerly SirVir Ltd. / Aposense Ltd.), based in Israel. No details regarding the molecular structure, active pharmaceutical ingredient, or specific therapeutic indication beyond phase 1 safety evaluation in healthy volunteers are currently available from public sources[1][3][5][6].

Brand names
Apo-Si-K170A-C76Apo-Si-K-170A-C76Apo-Si-K 170A-C76
Other names
Apo-Si-K170A-C76Apo-Si-K-170A-C76Apo-Si-K 170A-C76

Beyond the preview

Go deeper on Apo-Si-K170A-C76.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apo-Si-K170A-C76.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call